EP1165123A4 - 48 proteines humaines secretees - Google Patents

48 proteines humaines secretees

Info

Publication number
EP1165123A4
EP1165123A4 EP00916584A EP00916584A EP1165123A4 EP 1165123 A4 EP1165123 A4 EP 1165123A4 EP 00916584 A EP00916584 A EP 00916584A EP 00916584 A EP00916584 A EP 00916584A EP 1165123 A4 EP1165123 A4 EP 1165123A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00916584A
Other languages
German (de)
English (en)
Other versions
EP1165123A1 (fr
Inventor
Craig A Rosen
Steven M Ruben
George Komatsoulis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1165123A1 publication Critical patent/EP1165123A1/fr
Publication of EP1165123A4 publication Critical patent/EP1165123A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP00916584A 1999-03-26 2000-03-22 48 proteines humaines secretees Withdrawn EP1165123A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12659599P 1999-03-26 1999-03-26
US126595P 1999-03-26
US17154999P 1999-12-22 1999-12-22
US171549P 1999-12-22
PCT/US2000/007525 WO2000057903A2 (fr) 1999-03-26 2000-03-22 48 proteines humaines secretees

Publications (2)

Publication Number Publication Date
EP1165123A1 EP1165123A1 (fr) 2002-01-02
EP1165123A4 true EP1165123A4 (fr) 2002-09-11

Family

ID=26824840

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00916584A Withdrawn EP1165123A4 (fr) 1999-03-26 2000-03-22 48 proteines humaines secretees

Country Status (5)

Country Link
EP (1) EP1165123A4 (fr)
JP (1) JP2002539811A (fr)
AU (1) AU3766800A (fr)
CA (1) CA2368442A1 (fr)
WO (1) WO2000057903A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
EP1264842A4 (fr) * 2000-02-21 2004-09-15 Kureha Chemical Ind Co Ltd Nouvelles proteines et nouveaux genes codant ces proteines
CA2400981A1 (fr) 2000-02-21 2001-08-23 Kureha Chemical Industry Co., Ltd. Nouvelles proteines et nouveaux genes codant ces proteines
AU2001269836A1 (en) * 2000-06-16 2002-01-02 Incyte Genomics, Inc. Proteases

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792628A (en) * 1997-03-14 1998-08-11 Bowman; Michael Secreted protein, BA3.1, and polynucleotides encoding same
WO1998046756A1 (fr) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Compositions de proteines secretees ssp-1 et utilisations de ces compositions a des fins diagnostiques et therapeutiques
WO1998051790A1 (fr) * 1997-05-13 1998-11-19 Amrad Operations Pty. Ltd. Nouvelle molecule d'acide nucleique
EP0879887A1 (fr) * 1997-05-21 1998-11-25 Smithkline Beecham Corporation Un gène humain ressemblant à la protéine murine secretée SDF5 (ATG-1622)
WO2000009525A2 (fr) * 1998-08-03 2000-02-24 East Carolina University Agent comprenant des oligonucleotides antisens a faible teneur en adenosine, composition, trousse et traitements

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792628A (en) * 1997-03-14 1998-08-11 Bowman; Michael Secreted protein, BA3.1, and polynucleotides encoding same
WO1998046756A1 (fr) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Compositions de proteines secretees ssp-1 et utilisations de ces compositions a des fins diagnostiques et therapeutiques
WO1998051790A1 (fr) * 1997-05-13 1998-11-19 Amrad Operations Pty. Ltd. Nouvelle molecule d'acide nucleique
EP0879887A1 (fr) * 1997-05-21 1998-11-25 Smithkline Beecham Corporation Un gène humain ressemblant à la protéine murine secretée SDF5 (ATG-1622)
WO2000009525A2 (fr) * 1998-08-03 2000-02-24 East Carolina University Agent comprenant des oligonucleotides antisens a faible teneur en adenosine, composition, trousse et traitements

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 10 February 1999 (1999-02-10), XP002194741 *
DATABASE EMBL 12 November 1998 (1998-11-12), XP002194740 *
DATABASE EMBL 16 February 1998 (1998-02-16), XP002194739 *

Also Published As

Publication number Publication date
CA2368442A1 (fr) 2000-10-05
EP1165123A1 (fr) 2002-01-02
JP2002539811A (ja) 2002-11-26
AU3766800A (en) 2000-10-16
WO2000057903A2 (fr) 2000-10-05

Similar Documents

Publication Publication Date Title
EP1218408A4 (fr) 32 proteines humaines secretees
EP1212343A4 (fr) 52 proteines humaines secretees
EP1181390A4 (fr) 27 proteines humaines secretees
EP1224285A4 (fr) 27 proteines humaines secretees
EP1212342A4 (fr) 18 proteines secretees humaines
EP1226231A4 (fr) 19 proteines humaines secretees
EP1175438A4 (fr) Soixante-deux prot ines humaines s cr t es
EP1192278A4 (fr) 48 proteines secretees humaines
EP1192176A4 (fr) 49 proteines secretees humaines
EP1165827A4 (fr) 45 proteines humaines secretees
EP1175439A4 (fr) 49 proteines humaines secretees
EP1159284A4 (fr) 33 proteines humaines secretees
EP1189917A4 (fr) 48 proteines humaines secretees
EP1185543A4 (fr) 50 proteines humaines secretees
EP1224201A4 (fr) 32 proteines humaines secretees
EP1173477A4 (fr) 49 proteines humaines secretees
EP1206573A4 (fr) 26 proteines humaines secretees
EP1203005A4 (fr) 25 proteines secretees humaines
EP1165602A4 (fr) 49 proteines secretees par un etre humain
EP1169332A4 (fr) Proteines humaines secretees (49)
EP1171460A4 (fr) 48 proteines secretees humaines
EP1144614A4 (fr) Proteines humaines secretees (33)
EP1165828A4 (fr) 50 proteines humaines secretees
EP1185285A4 (fr) 49 proteines secretees humaines
EP1228082A4 (fr) Proteines humaines secretees 29

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010927

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020725

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030715

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041014